المؤلفون: Park SY; Department of Endocrinology and Metabolism, Kyung Hee University Hospital, Seoul 02447, Republic of Korea.; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea., Jun JE; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea.; Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea., Jeong IK; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea.; Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea., Ahn KJ; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea.; Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea., Chung HY; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea.; Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea., Hwang YC; Department of Endocrinology & Metabolism, Kyung Hee University School of Medicine, Seoul 02453, Republic of Korea.; Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.

المصدر: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Jun 17; Vol. 109 (7), pp. 1883-1890.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/blood , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Drug Therapy, Combination* , Ezetimibe*/therapeutic use , Ezetimibe*/administration & dosage , Anticholesteremic Agents*/administration & dosage , Anticholesteremic Agents*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome ; Republic of Korea/epidemiology ; Cholesterol, LDL/blood ; Myocardial Infarction/epidemiology ; Myocardial Infarction/prevention & control ; Stroke/prevention & control ; Stroke/epidemiology ; Adult ; Dyslipidemias/drug therapy ; Dyslipidemias/epidemiology ; Dyslipidemias/blood ; Retrospective Studies ; Cardiovascular Diseases/prevention & control ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/mortality

المؤلفون: Mahajan K; Department of Cardiology, Himachal Heart Institute, Mandi, Himachal Pradesh, India. Electronic address: Kunalmahajan442@gmail.com., Nagendra L; Department of Endocrinology, JSS Academy of Higher Education and Research, Mysore, India. Electronic address: drlakshminagendra@jssuni.edu.in., Dhall A; Department of Cardiology, Janakpuri Superspeciality Hospital, New Delhi, India., Dutta D; Department of Endocrinology, Center for Endocrinology Diabetes Arthritis & Rheumatism (CEDAR) Superspeciality Healthcare, Dwarka, New Delhi, India. Electronic address: deepdutta2000@yahoo.com.

المصدر: European journal of internal medicine [Eur J Intern Med] 2024 Jun; Vol. 124, pp. 99-107. Date of Electronic Publication: 2024 Feb 09.

نوع المنشور: Journal Article; Systematic Review; Meta-Analysis

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9003220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0828 (Electronic) Linking ISSN: 09536205 NLM ISO Abbreviation: Eur J Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Acute Coronary Syndrome*/drug therapy , Acute Coronary Syndrome*/blood , Ezetimibe*/therapeutic use , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/administration & dosage , Cholesterol, LDL*/blood, Humans ; Randomized Controlled Trials as Topic ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Drug Therapy, Combination ; Treatment Outcome

المؤلفون: Lee C; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; These authors contributed equally to this work., Kwak SH; Division of Pulmonology, Allergy and Critical Care Medicine, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.; These authors contributed equally to this work., Han J; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea., Shin JH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea., Yoo B; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea., Lee YS; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea.; Department of Biomedical Sciences, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea., Park JS; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea., Lim BJ; Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea., Lee JG; Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim YS; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea., Kim SY; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.; These authors contributed equally to this work., Bae SH; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul, Republic of Korea soohanbae@yuhs.ac.; Department of Biomedical Sciences, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.; These authors contributed equally to this work.

المصدر: The European respiratory journal [Eur Respir J] 2024 May 16; Vol. 63 (5). Date of Electronic Publication: 2024 May 16 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

مواضيع طبية MeSH: Ezetimibe*/therapeutic use , Ezetimibe*/pharmacology , Idiopathic Pulmonary Fibrosis*/drug therapy , Autophagy*/drug effects , Drug Repositioning* , Disease Models, Animal* , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/pharmacology, Animals ; Humans ; Mice ; Male ; Female ; Mice, Transgenic ; Bleomycin ; Lung/pathology ; Lung/drug effects ; Fibroblasts/metabolism ; Fibroblasts/drug effects ; Retrospective Studies ; Aged ; Middle Aged ; Mice, Inbred C57BL ; Myofibroblasts/drug effects ; Myofibroblasts/metabolism ; Cholesterol/metabolism

المؤلفون: Park IR; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea., Moon JS; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.

المصدر: Diabetes & metabolism journal [Diabetes Metab J] 2024 May; Vol. 48 (3), pp. 387-389. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Letter; Editorial

بيانات الدورية: Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2233-6087 (Electronic) Linking ISSN: 22336079 NLM ISO Abbreviation: Diabetes Metab J Subsets: MEDLINE

مواضيع طبية MeSH: Rosuvastatin Calcium*/therapeutic use , Rosuvastatin Calcium*/administration & dosage , Diabetes Mellitus, Type 2*/drug therapy , Ezetimibe*/therapeutic use , Ezetimibe*/administration & dosage , Anticholesteremic Agents*/therapeutic use , Anticholesteremic Agents*/administration & dosage , Drug Therapy, Combination*, Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage ; Blood Glucose/analysis ; Azetidines/therapeutic use ; Azetidines/administration & dosage ; Sulfonamides/therapeutic use ; Sulfonamides/administration & dosage ; Pyrimidines/therapeutic use ; Pyrimidines/administration & dosage

المؤلفون: Hameed I; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Shah SA; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Aijaz A; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Mushahid H; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan. Hasamushahid@gmail.com., Farhan SH; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Dada M; Department of Medicine, Ziauddin University, Karachi, Pakistan., Khan AB; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Amjad R; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Alvi F; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Murtaza M; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Zuberi Z; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Hamza M; Department of Internal Medicine, Albany Medical Center, Albany, USA.

المصدر: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2024 May; Vol. 24 (3), pp. 419-431. Date of Electronic Publication: 2024 Apr 05.

نوع المنشور: Journal Article; Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/adverse effects , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Ezetimibe*/administration & dosage , Ezetimibe*/therapeutic use , Ezetimibe*/adverse effects , Drug Therapy, Combination* , Atherosclerosis*/drug therapy , Anticholesteremic Agents*/administration & dosage , Anticholesteremic Agents*/adverse effects , Anticholesteremic Agents*/therapeutic use, Humans ; Cholesterol, LDL/blood ; Randomized Controlled Trials as Topic ; Cardiovascular Diseases ; Hypercholesterolemia/drug therapy ; Cholesterol, HDL/blood

المؤلفون: Muntner P; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA., Ghazi L; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA. lghazi@uab.edu., Jones J; Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA., Dhalwani N; Center for Observational Research, Amgen Inc., Thousand Oaks, CA, USA., Poudel B; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA., Wen Y; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA., Chen L; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA., Wang Z; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA., Bittner V; Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Kalich B; Amgen Inc., Thousand Oaks, CA, USA., Farkouh ME; Department of Medicine, Cedar-Sinai School of Medicine, Los Angeles, CA, USA., Woodward M; The George Institute for Global Health, School of Public Health, Imperial College London, London, UK.; The George Institute for Global Health, University of New South Wales, Sydney, Australia., Colantonio LD; Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Birmingham, AL, 35294, USA., Rosenson RS; Department of Medicine, Mount Sinai School of Medicine, New York, NY, USA.

المصدر: Advances in therapy [Adv Ther] 2024 Jun; Vol. 41 (6), pp. 2399-2413. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE

مواضيع طبية MeSH: Ezetimibe*/therapeutic use , PCSK9 Inhibitors* , Anticholesteremic Agents*/therapeutic use , Medication Adherence*/statistics & numerical data, Humans ; Male ; Middle Aged ; Female ; Aged ; Adult ; Antibodies, Monoclonal/therapeutic use ; United States ; Hypercholesterolemia/drug therapy ; Proprotein Convertase 9

المؤلفون: Lütjohann D, Stellaard F

المصدر: International journal of clinical pharmacology and therapeutics [Int J Clin Pharmacol Ther] 2024 Jul; Vol. 62 (7), pp. 295-306.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Dustri-Verlag Dr. K. Feistle Country of Publication: Germany NLM ID: 9423309 Publication Model: Print Cited Medium: Print ISSN: 0946-1965 (Print) Linking ISSN: 09461965 NLM ISO Abbreviation: Int J Clin Pharmacol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Cholesterol, LDL*/blood , Simvastatin*/pharmacology , Simvastatin*/therapeutic use , Anticholesteremic Agents*/pharmacology , Anticholesteremic Agents*/therapeutic use , Ezetimibe*/therapeutic use , Ezetimibe*/pharmacology , Cholesterol*/blood , Cholesterol*/biosynthesis , Hypercholesterolemia*/drug therapy , Hypercholesterolemia*/blood, Humans ; Male ; Adult ; Middle Aged ; Drug Therapy, Combination ; Intestinal Absorption/drug effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use

المؤلفون: Chang CC; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.; Division of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.; Division of Holistic and Multidisciplinary Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC., Huang HC; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.; Division of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC., Hsu SJ; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC., Pun CK; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC., Chuang CL; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.; Division of General Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC., Hou MC; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC., Lee FY; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.

المصدر: Journal of the Chinese Medical Association : JCMA [J Chin Med Assoc] 2024 May 01; Vol. 87 (5), pp. 463-470. Date of Electronic Publication: 2024 Feb 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wolters Kluwer Health Country of Publication: Netherlands NLM ID: 101174817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1728-7731 (Electronic) Linking ISSN: 17264901 NLM ISO Abbreviation: J Chin Med Assoc Subsets: MEDLINE

مواضيع طبية MeSH: Ezetimibe*/pharmacology , Ezetimibe*/therapeutic use , Rats, Sprague-Dawley* , Lipoproteins, LDL*/blood , Liver Cirrhosis, Biliary*/drug therapy , Oxidative Stress*/drug effects, Animals ; Rats ; Male ; Anticholesteremic Agents/therapeutic use ; Anticholesteremic Agents/pharmacology ; Azetidines/pharmacology ; Azetidines/therapeutic use

المؤلفون: Xue Z; Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China.; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Zhejiang, Hangzhou, China., Ye M; Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China., Jiang H; Department of Cardiology, The Fourth Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China., Li D; Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China.; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Zhejiang, Hangzhou, China., Hong X; Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China.; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Zhejiang, Hangzhou, China., Chen Z; Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China.; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Zhejiang, Hangzhou, China., Li Y; Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China.; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Zhejiang, Hangzhou, China., Zhou B; Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China.; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Zhejiang, Hangzhou, China., Zhang W; Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China.; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Zhejiang, Hangzhou, China., Wang M; Hangzhou Medical College Affiliated Lin An People's Hospital, Hangzhou, China.

المصدر: Clinical cardiology [Clin Cardiol] 2024 Jun; Vol. 47 (6), pp. e24301.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 7903272 Publication Model: Print Cited Medium: Internet ISSN: 1932-8737 (Electronic) Linking ISSN: 01609289 NLM ISO Abbreviation: Clin Cardiol Subsets: MEDLINE

مواضيع طبية MeSH: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , C-Reactive Protein*/analysis , C-Reactive Protein*/metabolism , Coronary Artery Disease*/blood , Coronary Artery Disease*/drug therapy , Biomarkers*/blood , Percutaneous Coronary Intervention*/methods , Ezetimibe*/therapeutic use, Humans ; Male ; Retrospective Studies ; Female ; Middle Aged ; Treatment Outcome ; Drug Therapy, Combination ; Aged ; Rosuvastatin Calcium/therapeutic use ; Atorvastatin/therapeutic use ; Cholesterol, LDL/blood ; Anticholesteremic Agents/therapeutic use ; Dyslipidemias/blood ; Dyslipidemias/drug therapy ; Dyslipidemias/diagnosis

المؤلفون: Wu L; Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China., Zhang B; Department of Neurology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China., Li C; Department of Radiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China., Zhuang Z; Department of Radiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China., Liu K; Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China., Chen H; Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China., Zhu S; Department of Neurology, Shenzhen Longhua District Central Hospital, The Affiliated Hospital of Guangdong Medical University, Shenzhen, Guangdong, China., Zhu J; Department of Neurology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China., Dai Z; Department of Neurology, Wuxi People's Hospital, Wuxi, Jiangsu, China., Huang H; Department of Neurology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China jiangyjnju@gmail.com 15219078888@139.com., Jiang Y; Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China jiangyjnju@gmail.com 15219078888@139.com.

المصدر: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2024 May 14; Vol. 95 (6), pp. 529-535. Date of Electronic Publication: 2024 May 14.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 2985191R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-330X (Electronic) Linking ISSN: 00223050 NLM ISO Abbreviation: J Neurol Neurosurg Psychiatry Subsets: MEDLINE

مواضيع طبية MeSH: Intracranial Arteriosclerosis*/drug therapy , Intracranial Arteriosclerosis*/complications , PCSK9 Inhibitors* , Ezetimibe*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Prospective Studies ; Cholesterol, LDL/blood ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Recurrence ; Anticholesteremic Agents/therapeutic use ; Ischemic Stroke/drug therapy ; Ischemic Stroke/complications ; Stroke/drug therapy ; Secondary Prevention